secwatch.observer — SEC 8-K summary
======================================

Issuer:     ZIMMER BIOMET HOLDINGS, INC. (ZBH)
CIK:        0001136869
Form:       8-K
Filed at:   2023-02-03T23:59:59+00:00
Accession:  0000950170-23-001740
Event type: earnings
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zimmer Biomet reports Q4 and FY2022 results; no figure details in filing
------------------------------------------------------------------------

- Company issued press release on February 3, 2023 covering Q4 and full-year 2022 financial performance.
- Actual financial results not provided in the 8-K text; refer to attached Exhibit 99.1.
- Investors should review the press release for specific revenue, EPS, and segment data.
- No forward-looking guidance or material events disclosed in the filing body.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1136869/000095017023001740/0000950170-23-001740-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1136869/000095017023001740/zbh-20230203.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-001740

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer